Internal Medicine, Infectious Disease · Phoenix, AZ
NPI
1477841914
Since 2011
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
2510 W Dunlap Ave, Suite 290
Phoenix, AZ, 85021
Phone (602) 789-0344
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,045 services
Medicare patients, 2024
259
Average age 74
Drug cost, 2024
$261K
416 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kumara Singaravelu was code 99232 (hospital e&m - subsequent), 739 times for 220 patients. In total Kumara Singaravelu billed 1,045 services in 6 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 739 | 220 | $60.04 | $44K |
| 99223 Hospital E&M - Initial | Facility | 142 | 138 | $131.15 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 100 | 65 | $89.54 | $8,954 |
| 99222 Hospital E&M - Initial | Facility | 53 | 52 | $97.48 | $5,166 |
By year: 2022 $84K for 1,036 services; 2023 $76K for 956 services; 2024 $78K for 1,045 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kumara Singaravelu prescribed most often to Medicare patients was Daptomycin, with 91 prescriptions and refills. In total Kumara Singaravelu wrote 416 Medicare prescriptions that cost $261K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 91 | 91 | 22 | $76K |
| Cefepime Hcl Generic | 51 | 51 | 13 | $5,427 |
| Ertapenem Ertapenem Sodium | 39 | 39 | Under 11 | $20K |
| Cefazolin Sodium Generic | 34 | 34 | Under 11 | $2,625 |
| Vancomycin Hcl Generic | 22 | 22 | Under 11 | $4,595 |
| Tigecycline Generic | 21 | 21 | Under 11 | $14K |
| Doxycycline Hyclate Generic | 18 | 26 | 18 | $554 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 18 | 18 | Under 11 | $3,375 |
| Cephalexin Generic | 15 | 29 | Under 11 | $855 |
| Teflaro Ceftaroline Fosamil Acetate | 11 | 11 | Under 11 | $37K |
| Fetroja Cefiderocol Sulfate Tosylate | 11 | 11 | Under 11 | $88K |
| Ceftriaxone Ceftriaxone Sodium | 11 | 11 | Under 11 | $621 |
Brand drugs: 52 claims; generic drugs: 364 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kumara Singaravelu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.